Asset / Drug

Mobile

Drug and asset intelligence for Mobile with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Stage: Development stage unavailable

Recent signals(2)

ClinicalJuly 1, 2026

Mobile Technology May Enhance Cardiac Rehabilitation Participation Post-Acute Coronary Syndrome

A study is exploring the use of mobile technology to improve participation in cardiac rehabilitation after acute coronary syndrome, where current utilization is below 30%.

ClinicalJuly 1, 2026

Mobile Health Intervention Trial for AYA Leukemia Adherence

A micro-randomized clinical trial is underway to assess a mobile health intervention aimed at improving oral chemotherapy adherence among adolescents and young adults with acute lymphoblastic leukemia.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

Acute Lymphoblastic Leukemia →

Therapeutic areas

Acute Lymphoblastic Leukemia →

Cardiology →

Oncology →

Rehabilitation →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.